Bumadizone
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Systematic (IUPAC) name | |
---|---|
2-[phenyl-(phenylamino)carbamoyl]hexanoic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 3583-64-0 |
ATC code | M01AB07 (WHO) |
PubChem | CID 19161 |
ChemSpider | 18080 |
UNII | ATD81G944M ![]() |
ChEBI | CHEBI:76119 |
ChEMBL | CHEMBL2105456 |
Chemical data | |
Formula | C19H22N2O3 |
Molar mass | 326.38958 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Bumadizone is a non-steroidal anti-inflammatory drug. It may be also named bumazidone.
References[edit]
Pyrazolones / Pyrazolidines |
|
---|---|
Salicylates | |
Acetic acid derivatives and related substances |
|
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) |
|
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications.
|
![]() |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |